Characteristic points of latest Standards of Medical Care in Diabetes-Reference-Cited by-同舟云学术

Characteristic points of latest Standards of Medical Care in Diabetes

Published:2024-03-09 Issue:1 Volume:5 Page:1-4
ISSN:
Container-title:Diabetes Research: Open Access
language:en
Short-container-title:Diab Res Open Access

Author:

Bando Hiroshi¹^ORCID

Affiliation:

1. Medical Research/Tokushima University, Tokushima, Japan; Japan Low Carbohydrate Diet Promotion Association (JLCDPA), Kyoto, Japan

Abstract

The American Diabetes Association (ADA) has presented the Standards of Medical Care in Diabetes-2024, introducing some impressive changes in description. The 2024 edition closely follows the ADA/EASD Consensus Statement. To evaluate various complications, BNP, NT-proBNP, ankle-brachial index (ABI), and the FIB-4 index are measured. The administration of SGLT2 inhibitors, GLP-1 receptor agonists, and tirzepatide is recommended for T2D adults with cardiovascular disease, heart failure (including HFrEF/HFpEF), and chronic kidney disease (CKD). For lipid control, bempedoic acid and inclisiran have been introduced. FreeStyle Libre 2 is now available, automatically sending data to the smartphone in real-time every minute.

Publisher

Asploro Open Access Publications

Reference19 articles.

1. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes-2024. Diabetes Care. 2024 Jan 1;47(Suppl 1):S314–S321.

2. Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P, Tankova T, Tsapas A, Buse JB. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022 Nov 1;45(11):2753-86. [PMID: 36148880]

3. Zhang A, El Hachem R, Goldman J. Preventing and Treating Metabolic Dysfunction-Associated Steatotic Liver Disease in People with Type 2 Diabetes: Promising Therapeutic Agents and Strategies. ADCES in Practice. 2024;12(1):38-42.

4. Zeng Y, Yin L, Yin X, Zhao D. Total cholesterol mediates the association between history of gestational diabetes mellitus and bone mineral density in US women aged 20-49 years. BMC Public Health. 2024 Jan 3;24(1):81. [PMID: 38172829]

5. Ahmad A, Lim LL, Morieri ML, Tam CH, Cheng F, Chikowore T, Dudenhöffer-Pfeifer M, Fitipaldi H, Huang C, Kanbour S, Sarkar S, Koivula RW, Motala AA, Tye SC, Yu G, Zhang Y, Provenzano M, Sherifali D, de Souza R, Tobias DK, Gomez MF, Ma RCW, Mathioudakis NN. Precision Prognostics for Cardiovascular Disease in Type 2 Diabetes: A Systematic Review and Meta-analysis. medRxiv [Preprint]. 2023 Aug 21:2023.04.26.23289177. Update in: Commun Med (Lond). 2024 Jan 22;4(1):11. [PMID: 37162891]